Kivu Bioscience
Latest round
- Series A
Last raised
- Oct 2024
Total raised
- $92M
Investors
- 7
About Kivu Bioscience
Kivu Bioscience was founded in 2024 in San Francisco, US, concentrating on biopharmaceutical developments.Kivu Bioscience specializes in the development of next-generation antibody-drug conjugates (ADCs) that target various forms of cancer. Its core offerings leverage proprietary technologies, such as the Synaffix site-specific conjugation platform and GlycoConnect™ technology, to create highly stable and effective ADCs. These products are designed to optimize therapeutic efficacy while minimizing off-tumor toxicity by utilizing advanced linker and payload combinations. Kivu's ADCs focus on enhancing homogeneity, stability, and potency, thus aiming to provide targeted cancer therapies with improved safety profiles.00 mn. Its revenue model revolves around partnerships and collaborations with other biopharmaceutical entities, focusing on the co-development and commercialization of ADCs. Transactions are structured through agreements that may include milestone payments and royalties, providing a framework for shared investment in research and development efforts. The company is focused on launching new ADC products designed to meet the needs of various cancer treatments, with plans to expand into new markets in North America and Europe by 2025.
Who invested in Kivu Bioscience
7 investors across 1 round
See all investors in Kivu Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 28, 2024
Amount
$92M
Investors
Questions about Kivu Bioscience
Who invested in Kivu Bioscience?
Kivu Bioscience has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kivu Bioscience raised?
Kivu Bioscience has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kivu Bioscience last raise money?
Kivu Bioscience's most recent round on record is a Series A, in Oct 2024.
What does Kivu Bioscience do?
Kivu Bioscience was founded in 2024 in San Francisco, US, concentrating on biopharmaceutical developments.
Where is Kivu Bioscience headquartered?
Kivu Bioscience is headquartered in San Francisco, US.
Which VCs invest in companies like Kivu Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kivu Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kivu Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.